Medicine recalls
|
| |
| The United States: AvKARE issues voluntary nationwide recall of Sildenafil 100mg Tablets and Trazodone 100mg Tablets due to product mix-up |
| |
The US Food and Drug Administration (FDA) announces that AvKARE is voluntarily recalling one lot of Sildenafil 100 mg Tablets (lot number: 36884) and one lot of Trazodone 100mg Tablets (lot number: 36783 ) to the consumer level. These products have been recalled due to a product mix-up of the listed two separate products inadvertently packaged together during bottling at a third party facility.
Unintentional consumption of sildenafil may pose serious health risks to consumers with underlying medical issues. For example, sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) lowering blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, or heart disease often take nitrates. Unintended intake of trazodone may result in adverse health consequences such as somnolence/sedation, dizziness, constipation, and blurred vision. These adverse events may be more concerning in elderly patients due to a subsequent increased risk for falls and driving impairment. To date, AvKARE has not received any reports of adverse events related to this recall.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/avkare-issues-voluntary-nationwide-recall-sildenafil-100mg-tablets-and-trazodone-100mg-tablets-due
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Thursday, Dec 10, 2020
Issued at HKT 16:00
|
| |
